MULTAQ

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Italy, Lithuania, Poland, Singapore, United Kingdom, United States

Active ingredients

The drug MULTAQ contains one active pharmaceutical ingredient (API):

1 Dronedarone UNII FA36DV299Q - DRONEDARONE HYDROCHLORIDE

Dronedarone is a multichannel blocker inhibiting the potassium currents (including IK(Ach), IKur, IKr, IKs) and thus prolonging cardiac action potential and refractory periods (Class III). It also inhibits the sodium currents (Class Ib) and the calcium currents (Class IV). It non-competitively antagonises adrenergic activities (Class II). Read about Dronedarone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MULTAQ Film-coated tablets	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01BD07	Dronedarone	C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BD Antiarrhythmics, class III
Discover more medicines within C01BD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02330989
Country: EE	Ravimiamet	Identifier(s): 1454071, 1454082, 1454093, 1454105
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 09591003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 028022, 028034
Country: FR	Base de données publique des médicaments	Identifier(s): 69213011
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 170665, 170666, 196968
Country: HK	Department of Health Drug Office	Identifier(s): 59499
Country: IE	Health Products Regulatory Authority	Identifier(s): 32621, 32653
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6412
Country: IT	Agenzia del Farmaco	Identifier(s): 039589039
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1052579, 1052580, 1052581, 1052582
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100217050
Country: SG	Health Sciences Authority	Identifier(s): 13849P
Country: US	FDA, National Drug Code	Identifier(s): 0024-4142, 55154-8104